RLMD
RLMD

Relmada Therapeutics Inc

NASDAQ · Pharmaceuticals
$3.88
+0.28 (+7.78%)
Analyst Consensus
Strong Buy
8 analysts
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +863.1% upside
Low Target $22.23
Average Target $37.37
High Target $43.38
Current Price $3.88
Current
$3.88
Target
$37.37
$22.23 $37.37 avg $43.38